Delivery Order SPE2DB24D2109-SPE2DB25FHXUD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,059.76 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $52,044.76 to supply Multaq 400 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 19, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $37,333.81 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $17,446.83 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with an ultimate completion date of August 19, 2025. This non-set-aside delivery order represents a single procurement action drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $9,432.60 delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of April 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp, valued at $3,193.37, for the supply of Multaq 400 mg tablets (60-count packaging) with an ultimate completion date of September 2, 2025. This contract utilizes firm fixed-price pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed price contract with a ceiling value of $1,529.88. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 29, 2025. AmerisourceBergen will fulfill this pharmaceutical supply requirement from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,351.04 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) valued at $7,313.70 under a firm fixed price contract. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXUDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $53,458.59 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) with a firm fixed price arrangement. This competitively awarded, non-set-aside contract is scheduled for completion by August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to fulfill this pharmaceutical supply requirement through its existing contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen Drug Corp provides critical medical commodities including specialty medications, brand-name and generic drugs, and related healthcare supplies to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.5k | 8/26/25 |